Abstract

The aim of the present study was to develop stable nanoparticulate formulation for sustained release of Prednisolone. Chitosan nanoparticles were prepared by ionic gelation method using tripolyphosphate as cross-linking agent. Different nanoparticulate formulations were prepared by using 32 factorial design in which varying the concentration of chitosan (0.1% to 0.3%), concentration of tripolyphosphate (0.02% to 0.03%) as two factors. The effect of these factors on the particle size, % entrapment efficiency and in vitro drug release was evaluated to develop an optimized formulation. Particle size, % entrapment efficiency and in vitro release of optimized formulation were found to be 168.1nm, 78.53% and 70.80% respectively. ANOVA study applied with p < 0.01 suggests that model is significant & Contour, Surface response & overlay plot was contract to optimize the formulation. Optimized formulation (C-10) showed sustained drug release at the end of 11th hour compared to other formulations. Based on release kinetic model, the drug release data fit well to higuchi model (r2 = 0.9935) indicating the diffusion limited drug release from nanoparticles. Drug release mechanism according to Korsmeyer-Peppas model was found anomalous transport (n = 0.5847). Scanning electron microscopy (SEM) revealed that the nanoparticles were spherical in shape and there was no crystallization of drug and other excipients. Drug-excipients compatibility confirmed by FTIR study.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call